* Orthofix Medical Inc OFIX.OQ OFIX.O is expected
to show a
fall in quarterly revenue when it reports results on May 6.
* The Lewisville Texas-based company is expected to report
a
1.2% decrease in revenue to $104.353 million from $105.59
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Orthofix Medical
Inc is
for earnings of 9 cents per share. For the same quarter last
year, the company reported earnings of 17 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Orthofix
Medical
Inc is $51.5, above its last closing price of $31.40.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.13 0.13 0.27 Beat 107.7
Sep. 30 2021 0.11 0.11 0.10 Missed -10.4
Jun. 30 2021 0.13 0.11 0.32 Beat 190.9
Mar. 31 2021 0.01 0.02 0.17 Beat 709.5
Dec. 0.17 0.19 0.44 Beat 126.8
31 2020
Sep. 30 2020 -0.29 -0.36 0.31 Beat 185.2
Jun. 30 2020 -1.07 -1.08 -0.59 Beat 45.4
Mar. 31 2020 0.07 0.06 0.09 Beat 50
This summary was machine generated May 4 at 17:04 GMT. All
figures in US dollars unless otherwise stated